会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明授权
    • Enhanced transport using membrane disruptive agents
    • 增强运输使用膜破坏剂
    • US06835393B2
    • 2004-12-28
    • US09226044
    • 1999-01-05
    • Allan S. HoffmanPatrick StaytonOliver W. PressDavid TirrellNiren MurthyChantal LackeyLawrence A. CrumPierre D. MouradTyrone M. Porter
    • Allan S. HoffmanPatrick StaytonOliver W. PressDavid TirrellNiren MurthyChantal LackeyLawrence A. CrumPierre D. MouradTyrone M. Porter
    • A61K9127
    • A61K47/481A61K41/0028A61K41/0047A61K47/48376A61K47/6801
    • Compositions and methods for transport or release of therapeutic and diagnostic agents or metabolites or other analytes from cells, compartments within cells, or through cell layers or barriers are described. The compositions include a membrane barrier transport enhancing agent and are usually administered in combination with an enhancer and/or exposure to stimuli to effect disruption or altered permeability, transport or release. In a preferred embodiment, the compositions include compounds which disrupt endosomal membranes in response to the low pH in the endosomes but which are relatively inactive toward cell membranes, coupled directly or indirectly to a therapeutic or diagnostic agent. Other disruptive agents can also be used, responsive to stimuli and/or enhancers other than pH, such as light, electrical stimuli, electromagnetic stimuli, ultrasound, temperature, or combinations thereof. The compounds can be coupled by ionic, covalent or H bonds to an agent to be delivered or to a ligand which forms a complex with the agent to be delivered. Agents to be delivered can be therapeutic and/or diagnostic agents. Treatments which enhance delivery such as ultrasound, iontopheresis, and/or electrophereis can also be used with the disrupting agents.
    • 描述了用于从细胞,细胞内的细胞室或通过细胞层或屏障转运或释放治疗和诊断试剂或代谢物或其它分析物的组合物和方法。 组合物包括膜屏障转运增强剂,并且通常与增强剂和/或暴露于刺激物一起施用以实现破坏或改变渗透性,运输或释放。 在优选的实施方案中,组合物包括响应于内体中的低pH而破坏内体膜的化合物,但是与细胞膜相对无活性的化合物,直接或间接地与治疗剂或诊断剂偶联。 还可以使用其它破坏剂,对除了pH之外的刺激和/或增强剂如光,电刺激,电磁刺激,超声,温度或其组合都有反应。 这些化合物可以通过离子,共价键或H键连接到待递送的试剂上,或者与配制剂形成配合物。 待递送的药剂可以是治疗和/或诊断剂。 增强递送的治疗如超声波,离子分离和/或电泳也可与破坏剂一起使用。
    • 10. 发明授权
    • Ultrasound therapy head configured to couple to an ultrasound imaging probe to facilitate contemporaneous imaging using low intensity ultrasound and treatment using high intensity focused ultrasound
    • 超声治疗头被配置为耦合到超声成像探针以促进使用低强度超声的同时成像和使用高强度聚焦超声
    • US06716184B2
    • 2004-04-06
    • US10166795
    • 2002-06-07
    • Shahram VaezyRoy W. MartinStephen J. CarterGeorge W. KeilmanVictor Y. FujimotoLawrence A. Crum
    • Shahram VaezyRoy W. MartinStephen J. CarterGeorge W. KeilmanVictor Y. FujimotoLawrence A. Crum
    • A61N700
    • A61B8/4488A61B8/06A61B8/0833A61B8/12A61B8/4209A61B8/4254A61B8/445A61B8/4483A61B8/481A61B8/483A61B2017/4216A61B2090/378A61N7/02
    • Method and apparatus for the simultaneous use of ultrasound on a probe for imaging and therapeutic purposes. The probe limits the effects of undesirable interference noise in a display by synchronizing high intensity focused ultrasound (HIFU) waves with an imaging transducer to cause the noise to be displayed in an area of the image that does not overlap the treatment site. In one embodiment, the HIFU is first energized at a low power level that does not cause tissue damage, so that the focal point of the HIFU can be identified by a change in the echogenicity of the tissue caused by the HIFU. Once the focal point is properly targeted on a desired treatment site, the power level is increased to a therapeutic level. The location of each treatment site is stored and displayed to the user to enable a plurality of spaced-apart treatment sites to be achieved. As the treatment progresses, any changes in the treatment site can be seen in the real time, noise-free image. A preferred application of the HIFU waves is to cause lesions in blood vessels, so that the supply of nutrients and oxygen to a region, such as a tumor, is interrupted. The tumor will thus eventually be destroyed. In a preferred embodiment, the HIFU is used to treat disorders of the female reproductive system, such as uterine fibroids. The HIFU treatment can be repeated at spaced-apart intervals, until any remaining fibroid tissue is destroyed.
    • 用于在探针上同时使用超声波用于成像和治疗目的的方法和装置。 该探针通过将高强度聚焦超声波(HIFU)波与成像换能器同步来将显示中的不期望的干扰噪声的影响限制在使得噪声显示在不与治疗部位重叠的图像区域中。 在一个实施例中,HIFU首先在不会导致组织损伤的低功率水平下通电,使得可以通过由HIFU引起的组织的回波反射性的变化来识别HIFU的焦点。 一旦焦点适当地对准所需的治疗部位,功率水平就提高到治疗水平。 每个治疗部位的位置被存储并显示给使用者,以实现多个间隔开的治疗部位。 随着治疗的进行,治疗部位的任何变化都可以在实时,无噪音的图像中看到。 HIFU波的优选应用是引起血管中的损伤,使得诸如肿瘤等区域的营养物和氧气供应被中断。 因此肿瘤最终将被破坏。 在优选的实施方案中,HIFU用于治疗女性生殖系统的疾病,例如子宫肌瘤。 可以间隔间隔重复HIFU治疗,直到残留的纤维组织被破坏为止。